Search
Niagen Bioscience Inc
NAGEAdd to Watchlist
3.480USD
+0.080+2.35%
Market hours （ET）Quotes delayed by 15 min
277.14MMarket Cap
14.90P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Niagen Bioscience Inc is 8.80, ranking 53 out of 385 in the Biotechnology & Medical Research industry. The average price target is 14.00, with a high of 23.00 and a low of 12.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
12.417
Target Price
+265.20%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Niagen Bioscience Inc
NAGE
6
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Niagen Bioscience Inc's expected revenue for the next quarter?
Niagen Bioscience Inc's expected revenue is 30.69M.
What is Niagen Bioscience Inc's price target?
Analysts forecast that Niagen Bioscience Inc's price target is USD 14.00, with the highest forecast at USD 23.00 and the lowest forecast at USD 12.00.
How have Niagen Bioscience IncNAGE's recent earnings per share performed?
The market expectation was USD 0.08, while Niagen Bioscience IncNAGE's earnings per share (EPS) for the previous quarter was USD 0.05. EPS for the next quarter is expected at USD 0.02.
What is the analyst rating for Niagen Bioscience Inc?
Based on the ratings of Niagen Bioscience Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.